Company CytRx Corporation Other OTC
Equities
CYTR
US2328286081
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 09/01/22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 30/09/07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 16/03/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 28/07/21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 26/07/22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 11/07/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 495,092 | 492,306 ( 99.44 %) | 0 | 99.44 % |
Company contact information
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.comSector
1st Jan change | Capi. | |
---|---|---|
+28.79% | 49.18B | |
+0.76% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.18% | 26.09B | |
-22.50% | 18.71B | |
+8.11% | 13.26B | |
+32.17% | 12.32B | |
-0.43% | 11.99B |